X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. 

Biotechnology

X4 Pharmaceuticals

Paula Ragan

Christophe Arbet-Engels

Mary DiBiase

Mark Baldry

Adam Mostafa

Art Taveras

The leadership team at X4 Pharmaceuticals has experience in a variety of industries, including pharmaceuticals, biologics, and supply chain management. They also have a wide range of educational backgrounds, with degrees in economics, industrial pharmacy, and pharmacy.

Leadership Team

CEO and Executive Team

Board of Directors

Leadership Team

About

Team members

Other teams at X4 Pharmaceuticals

CEO and Executive Team

Board of Directors